| Kerry Councilman, MD | |
|
1348 Ne Cushing Dr, Bend, OR 97701-3876 | |
| (541) 382-7696 | |
| Not Available |
| Full Name | Kerry Councilman |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 20 Years |
| Location | 1348 Ne Cushing Dr, Bend, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497904452 | NPI | - | NPPES |
| 20824713 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 48166 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Oregon Pathology Consultants Pc | 2860488236 | 8 |
News Archive
In a preliminary study, HIV-infected patients with excess abdominal fat who received the growth hormone-releasing hormone analog tesamorelin for 6 months experienced modest reductions in liver fat, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS.
Researchers from the Catalan Institute of Oncology have studied the impact of the law banning smoking in public places such as bars and restaurants on those working in these places. The results are positive - 5% of waiters have stopped smoking, and the number of cigarettes smoked by those who still smoke has fallen by almost 9%.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
› Verified 7 days ago
| Entity Name | Central Oregon Pathology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124140926 PECOS PAC ID: 2860488236 Enrollment ID: O20040421001470 |
News Archive
In a preliminary study, HIV-infected patients with excess abdominal fat who received the growth hormone-releasing hormone analog tesamorelin for 6 months experienced modest reductions in liver fat, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS.
Researchers from the Catalan Institute of Oncology have studied the impact of the law banning smoking in public places such as bars and restaurants on those working in these places. The results are positive - 5% of waiters have stopped smoking, and the number of cigarettes smoked by those who still smoke has fallen by almost 9%.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kerry Councilman, MD 1348 Ne Cushing Dr, Bend, OR 97701-3876 Ph: (541) 382-7696 | Kerry Councilman, MD 1348 Ne Cushing Dr, Bend, OR 97701-3876 Ph: (541) 382-7696 |
News Archive
In a preliminary study, HIV-infected patients with excess abdominal fat who received the growth hormone-releasing hormone analog tesamorelin for 6 months experienced modest reductions in liver fat, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS.
Researchers from the Catalan Institute of Oncology have studied the impact of the law banning smoking in public places such as bars and restaurants on those working in these places. The results are positive - 5% of waiters have stopped smoking, and the number of cigarettes smoked by those who still smoke has fallen by almost 9%.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety and were published earlier this year in "JACC: Cardiovascular Interventions".
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
› Verified 7 days ago
Dr. Laurel B. Yocom, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1348 Ne Cushing Dr, Suite 200, Bend, OR 97701 Phone: 541-382-7696 | |
Joseph Alton Hughes, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1348 Ne Cushing Dr, Bend, OR 97701 Phone: 541-382-7696 | |
Dr. James Lewis Judd, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1348 Ne Cushing Dr, Bend, OR 97701 Phone: 541-693-2667 | |
Brian K. Stewart, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1348 Ne Cushing Dr, Suite 200, Bend, OR 97701 Phone: 541-382-7696 Fax: 541-389-5724 | |
Dr. Osvaldo A. Schirripa, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 143 Sw Shevlin Hixon Dr, Suite #203, Bend, OR 97702 Phone: 541-633-7172 | |
Stephen Maurice Russell, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 3391 Nw Panorama Dr, Bend, OR 97701 Phone: 541-693-4376 |